Navigation Links
UC research shows risk of ALS exposure in Gulf War veterans is time limited
Date:6/6/2008

CINCINNATIA new study, led by researchers at the University of Cincinnati (UC), says that cases of Amyotrophic Lateral Sclerosis (ALS) among soldiers who served in the first Persian Gulf War were caused by certain events during their deployment to the war zone, meaning the exposure and illness is not as widespread as previously thought.

The study is being published in the July issue of Neuroepidemiology.

Ronnie Horner, PhD, lead author of the study, along with colleagues at Duke University Medical Center found that among the 124 cases of ALS studied, 48 occurred within those soldiers deployed to the Persian Gulf region.

Horner says most of the deployed soldiers who developed ALS had disease onset in 1996 or earlier.

"The outbreak was time-limited," he continues. "We actually saw a declining risk after 1996; therefore, the risk is not continual. The pattern of disease onset suggests that whatever exposure occurred among these soldiers most likely happened sometime between August 1990 and July 1991, the period of the first Gulf War."

ALS is a fatal neurological disease caused by the degeneration of nerve cells in the central nervous system that control voluntary muscle movement. It is commonly known as Lou Gehrig's Disease after the baseball Hall of Famer who died of it in 1941.

Horner, director for the Institute for the Study of Health at UC, says it is an illness that usually affects people in their 60s and 70s.

"When it started occurring in veterans in their 30s and 40sa low-risk populationresearchers knew that something had occurred during that conflict to cause these affects."

The recent study builds on research published in 2003 that showed there was a two-fold increased risk of ALS among 1991 Gulf War veterans.

To gather this information, researchers screened medical files at Veteran Affairs and Department of Defense hospitals nationwide in search of patients with ALS or other motor neuron diseases. They also advertised a toll-free telephone number for Gulf War veterans to call if they had been diagnosed with ALS.

After identifying patients, the investigators verified their illness through medical record review or medical examination by neurologists who were experts in ALS.

The study indicated that these veterans had a higher-than-expected risk of ALS but did not answer whether the risk had diminished over time or what had caused the risk.

Now, researchers at Duke, Durham Veterans Affairs Medical Center and UC are taking it a step further and are conducting studies to find possible exposures these veterans had while deployed to the Persian Gulf area that may be the cause of the outbreak.

"We want to find out if there are specific areas where the soldiers moved through," Horner says. In addition, he says researchers are looking at the contributions of specific incidentsfor example, the demolition of the munitions dump at Khamisiyah, Iraq, that released a low level of nerve agent, and smoke from the oil well firesto the heightened risk of the disease in soldiers.

"With this information, we may be able to discover what caused the ALS outbreak and hopefully prevent similar instances from occurring in the future," Horner says.


'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati
Source:Eurekalert

Related medicine news :

1. Charles D. McCrary Joins Southern Research Institute Board of Directors
2. New MRI to debut in African nation of Malawi; will save lives, advance malaria research
3. The Foundation for Biomedical Research (FBR) Releases Feature DVD Majestic for World Premiere
4. Researchers determine risk factors for infection after liver transplantation
5. South African scientists access European research via EMBC agreement
6. 3-1-1 Travel Bag Donates to St. Jude Childrens Research Hospital
7. Tufts researcher leads revision of osteoporosis guidelines
8. Best Practices, LLC: Create Strong Leadership to Add Value to Market Research Function
9. New Diabetes Research To Be Presented at FOCIS Annual Meeting
10. Public funding impacts progress of human embryonic stem cell research
11. Discovery of new signal pathway important to diabetes research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... The ... formally announce its Not a Moment to Lose fundraising campaign. As the V ... dedicated to declaring victory over cancer. The campaign aims to raise $200 million ...
(Date:12/6/2016)... Pittsburgh, PA (PRWEB) , ... December 06, 2016 ... ... particle identification and characterization laboratories, is now offering HIAC particle counting and sizing ... available immediately. , Gateway Analytical instituted the new service as a response to ...
(Date:12/6/2016)... Switzerland (PRWEB) , ... December 06, 2016 , ... ... a one-stop portal for all the knowledge resources, including white papers, guides, ... certificates, and more. , To access more than 9,000 documents, webinars and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... ... ... Keeping Gift Season Safe, In a season stacked with gift-giving opportunities, it's ... recipients. This is the idea behind Safe Toys and Gifts Month, which sets aside ... good gifts for children. For companies that produce goods that fall into this category, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 2016  Breckenridge Pharmaceutical, Inc. announced today that ... with development and manufacturing partner Gland Pharma Limited ... of this agreement, Breckenridge will market and distribute ... the United States . The deal includes ... products cover a wide range of indications.  This ...
(Date:12/5/2016)... Oregon and PUNE, India , ... new report by Allied Market Research, titled, "Global Cancer Biomarkers ... global revenue of cancer biomarkers market is projected to reach ... a CAGR of 13.3% from 2016 to 2022. Omic technologies ... in 2015 and is expected to maintain its dominance during ...
(Date:12/5/2016)... Dec. 5, 2016  Recently Zymo Research announced ... predictor, known as Horvath,s Clock. Based on this ... analysis service to academic and biopharma scientific researchers ... sample, other than sperm. The service ... biological age versus chronological age following drug treatments ...
Breaking Medicine Technology: